Specialist and experienced pricing and market access consultancy
We will develop and implement a successful launch strategy for your product.
We build payer focussed pricing and market access strategies to enable commercial success.
We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.
Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.
Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.
Individual solutions to suit you
We adapt our working style to reflect your needs
We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies
We react quickly and effectively to provide the best support possible
Payer value proposition development and understanding evidence requirements to secure pricing and re…
Read moreAlmost a decade after it’s inception, what have we learned from the UK early access to medicines sch…
Read moreMHRA announces UK will introduce new framework aimed at making the manufacture of innovative medicin…
Read moreNICE have recommended Enhertu for the treatment of HER2-positive breast cancer within a managed acce…
Read moreIn a phase 3 study, Crovalimab was found to be efficacious and well tolerated in people with paroxys…
Read moreBiopharmas offer significant discounts on their products in China, to try and score spots on the cou…
Read moreJapan’s largest drugmaker Takeda says it aims to seek marketing authorisation for its TAK-755 enzy…
Read moreGermany’s BPI and vfa advise that the implementation of the European Health Technology Assessment (E…
Read moreTwo global pharma companies withdraw from the UK’s Voluntary Scheme for Branded Medicines Pricing …
Read more